Screener
Neuropace, Inc. NPCE Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s total cost of revenue?
- Neuropace, Inc. (NPCE) reported total cost of revenue of $3.92M in Q2 2026.
- How has Neuropace, Inc.'s total cost of revenue changed year-over-year?
- Neuropace, Inc.'s total cost of revenue increased by 19.2% year-over-year, from $3.29M to $3.92M.
- What is the long-term trend for Neuropace, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s total cost of revenue has grown at a 15.2% compound annual growth rate (CAGR), from $11.75M to $20.67M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Neuropace, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude